Back to company

MINERVAX ApS: Financial statements 2014

CVR: 32673287

MINERVAX ApS (CVR 32673287) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -5,356,678 and a net result of DKK -4,412,692 compared with DKK -2,146,519 the year before. Equity amounted to DKK 13,515,506. The solvency ratio was 74.7%.

Gross Profit
-5,356,678 kr.
Profit/Loss
-4,412,692 kr.
Equity
13,515,506 kr.
Total Assets
18,092,802 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--5.4 mio.-4.4 mio.13.5 mio.-
20134.6 mio.-2.6 mio.-2.1 mio.-719 t.-
2012--1.1 mio.-846 t.1.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MINERVAX ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

Carsten Schou joins the board of MINERVAX ApSMay 30, 2014

As of May 30, 2014, Carsten Schou has joined the board of directors of MINERVAX ApS.

Line Holten Reimer leaves the board of MINERVAX ApSMay 30, 2014

As of May 30, 2014, Line Holten Reimer has left the board of directors of MINERVAX ApS.

MINERVAX ApS: The 2013 annual report is outMay 1, 2014

MINERVAX ApS has published its annual report for 2013. Revenue came to DKK 4,568,982, and the net result was DKK -2,146,519.

Sten Verland joins the board of MINERVAX ApSJan 2, 2014

As of January 2, 2014, Sten Verland has joined the board of directors of MINERVAX ApS.

Nanna Liebach Lüneborg joins the board of MINERVAX ApSJan 2, 2014

As of January 2, 2014, Nanna Liebach Lüneborg has joined the board of directors of MINERVAX ApS.

Carl Fredrik Siwmark joins the board of MINERVAX ApSJan 2, 2014

As of January 2, 2014, Carl Fredrik Siwmark has joined the board of directors of MINERVAX ApS.

Carl Gunnar Lindahl leaves the board of MINERVAX ApSJan 2, 2014

As of January 2, 2014, Carl Gunnar Lindahl has left the board of directors of MINERVAX ApS.

About MINERVAX ApS

MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees. In 2025, the company reported a net result of DKK -31,530,000 compared with DKK -29,126,000 the year before. Equity amounted to DKK 9,787,000.